ahlam1399
06-28-2016, 04:02 AM
UPDATE 1-Mayne Pharma nears deal for Teva assets -source
June 27 (Reuters) - Australia's Mayne Pharma Group Ltd on Tuesday said it will acquire U.S. generic productsfrom Teva Pharmaceuticals for $652 million, helping itpropel into the top 2 in the general oral contraceptives marketin the United States.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=28hHmkC5H4g:1ao1UNDeNRo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=28hHmkC5H4g:1ao1UNDeNRo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=28hHmkC5H4g:1ao1UNDeNRo:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=28hHmkC5H4g:1ao1UNDeNRo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=28hHmkC5H4g:1ao1UNDeNRo:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/28hHmkC5H4g
June 27 (Reuters) - Australia's Mayne Pharma Group Ltd on Tuesday said it will acquire U.S. generic productsfrom Teva Pharmaceuticals for $652 million, helping itpropel into the top 2 in the general oral contraceptives marketin the United States.http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=28hHmkC5H4g:1ao1UNDeNRo:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=28hHmkC5H4g:1ao1UNDeNRo:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=28hHmkC5H4g:1ao1UNDeNRo:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=28hHmkC5H4g:1ao1UNDeNRo:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=28hHmkC5H4g:1ao1UNDeNRo:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/28hHmkC5H4g